Literature DB >> 25512220

Experience with the Enlite sensor in a multicenter pediatric study.

Keira Evans1, Christine Richardson2, Alanna Landry3, Janice Muileboom4, Lynne Cormack5, Margaret L Lawson6.   

Abstract

PURPOSE: The purpose of this article is to outline the experience of certified diabetes educators (CDEs) using the Enlite continuous glucose monitoring sensor system in a pediatric multicenter randomized controlled trial. Continuous glucose monitoring (CGM) is becoming popular as a tool for educators and families to improve glycemic control. CGM can be a valuable educational tool to demonstrate to the user the impact of insulin dosing and effects of physical activity, food intake, and other life events such as work, illness, and stress on their glycemic control. The authors will share education tips and practical applications for diabetes educators to facilitate education and sustained use of Enlite glucose sensors in children and adolescents using insulin pump therapy.
CONCLUSIONS: The Enlite glucose sensor is a comfortable and user-friendly device. Improvements to both the insertion device and the Enlite glucose sensor have resulted in improved level of comfort on insertion and with ongoing wear, which may translate into greater adherence and effectiveness.
© 2014 The Author(s).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25512220     DOI: 10.1177/0145721714560589

Source DB:  PubMed          Journal:  Diabetes Educ        ISSN: 0145-7217            Impact factor:   2.140


  2 in total

1.  In-home nighttime predictive low glucose suspend experience in children and adults with type 1 diabetes.

Authors:  Laurel H Messer; Peter Calhoun; Bruce Buckingham; Darrell M Wilson; Irene Hramiak; Trang T Ly; Marsha Driscoll; Paula Clinton; David M Maahs
Journal:  Pediatr Diabetes       Date:  2016-04-29       Impact factor: 4.866

2.  Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial.

Authors:  Margaret L Lawson; Kate C Verbeeten; Jennilea M Courtney; Brenda J Bradley; Karen McAssey; Cheril Clarson; Susan Kirsch; Jacqueline R Curtis; Farid H Mahmud; Christine Richardson; Tammy Cooper; Jason Chan; Ken Tang
Journal:  Pediatr Diabetes       Date:  2020-11-04       Impact factor: 4.866

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.